Joimax reported a record revenue in the third quarter of 2017.
Here are four highlights:
1. The company saw 60 percent growth year-over-year in the third quarter of 2017.
2. Joimax USA is on track to nearly double its 2016 revenues in 2017.
3. The company attributes the growth to increasing user interest and patient demand for endoscopicspine surgery.
4. Joimax will feature its Shrill Deflector Blades for spinal compression as well as its Vaporflex bipolar forceps for TESSYS and iLESSYS at EUROSPINE in Dublin, Ireland, from Oct. 11 to Oct. 13.